Diagante
Preanalytical diagnostic device maker for solid tissue and bone/joint infection sample handling in clinical labs
Highlights
- New on EvolcAdded 2026-11-11
About Diagante
Diagante develops preanalytical in vitro diagnostic medical devices based on a programmable nanomaterial that preserves and processes solid biological samples. Its first product, Tissutainer, targets bone and joint infection diagnosis by protecting sample vitality until laboratory analysis and releasing infecting organisms from solid tissue.
The company sells to orthopaedic practices and healthcare professionals working with surgical biopsies and clinical laboratories. Its stated focus is on the sample-handling step before laboratory analysis, without changing existing sample workflows.
Diagante was founded in 2020 and is headquartered in Neuilly-sur-Seine, France, according to its registry record. Its website lists an office in Montigny-le-Bretonneux, France. Its founding team includes co-founders Cecile Chevalier (CEO), Pr. Martin Rottman (CMO and CSO) and Virginie Lebidois (COO).
Product: Tissutainer, a preanalytical in vitro diagnostic device using programmable nanomaterial for solid tissue sample preservation and extraction.
Jobs at Diagante
More biotech & pharma companies
Dianosic
Develops long-acting intranasal drug-delivery products for chronic respiratory and central nervous system therapiesNew on EvolcDiogenx
Develops recombinant protein therapies to regenerate insulin-producing beta cells for people with type 1 diabetesDiscngine
Scientific software and tailored IT services for life-science research and early drug discovery teamsDna Gensee
Plant DNA testing and R&D project services for industrial companies using plants or algae in their productsNew on EvolcDNA Script
Benchtop enzymatic DNA synthesis system for labs that need ready-to-use oligos in-house, overnightRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
